MedTrace Logo

Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens

NCT01322685 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2011-03-24

No results posted yet for this study

Summary

The purpose of this study is to study the Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens. Subjects are divided into two groups which are health group and Tuberculosis or lung cancer group in order to compare with the difference.

Conditions

Sponsors & Collaborators

  • Taipei Medical University WanFang Hospital

    lead OTHER

Principal Investigators

  • Kuo-Sheng Hung · Taipei Medical University WanFang Hospital

Eligibility

Min Age
17 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-07-31
Completion
2011-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01322685 on ClinicalTrials.gov